MSR41 Predicting Antimicrobial Resistance in Uncomplicated Urinary Tract Infections Using Machine Learning

Autor: K Kponee-Shovein, WY Cheng, A Marijam, P Schwab, C Gao, D Indacochea, D Ferrinho, FS Mitrani-Gold, L Pinheiro, J Royer, AV Joshi

Publikováno v: Value in Health. 25:S357

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5db619905c241f6267a8059d16d400cb
https://doi.org/10.1016/j.jval.2022.09.1772

Risk of collagen-related disorders and neurological events among patients with uncomplicated urinary tract infection following short treatment with fluoroquinolones: a cohort study.

Autor: Mitrani-Gold FS; GSK, Collegeville, Pennsylvania, USA., Ju S; GSK, London, United Kingdom., Drysdale M; London School of Hygiene and Tropical Medicine, London, United Kingdom., Schultze A; London School of Hygiene and Tropical Medicine, London, United Kingdom., Mu G; GSK, Collegeville, Pennsylvania, USA., Logie J; GSK, London, United Kingdom.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Dec 05; Vol. 68 (12), pp. e0069024. Date of Electronic Publication: 2024 Oct 29.

Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in Escherichia coli-Caused Uncomplicated Urinary Tract Infection.

Autor: Shields RK; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Cheng WY; Analysis Group, Inc., Boston, Massachusetts, USA., Kponee-Shovein K; Analysis Group, Inc., Boston, Massachusetts, USA., Indacochea D; Analysis Group, Inc., Boston, Massachusetts, USA., Gao C; Analysis Group, Inc., Boston, Massachusetts, USA., Kuwer F; Analysis Group, Inc., Boston, Massachusetts, USA., Joshi AV; GSK, Collegeville, Pennsylvania, USA., Mitrani-Gold FS; GSK, Collegeville, Pennsylvania, USA., Schwab P; GSK, Collegeville, Pennsylvania, USA., Ferrinho D; GSK, Collegeville, Pennsylvania, USA., Mahendran M; Analysis Group, Inc., Boston, Massachusetts, USA., Pinheiro L; Analysis Group, Inc., Boston, Massachusetts, USA., Royer J; Analysis Group, Inc., Boston, Massachusetts, USA., Preib MT; GSK, Collegeville, Pennsylvania, USA., Han J; GSK, Collegeville, Pennsylvania, USA., Colgan R; Department of Family Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 16; Vol. 79 (2), pp. 295-304.

Reply to Editorial Comment on "Likelihood of Antimicrobial Resistance in Urinary E. coli Isolates Among US Female Patients with Recurrent Versus Non-Recurrent uUTI".

Autor: Fromer DL; Hackensack University Medical Center, Hackensack, NJ. Electronic address: Debra.Fromer@hmhn.org., Mulgirigama A; GSK, Surrey, United Kingdom., Mitrani-Gold FS; GSK, Collegeville, PA.

Publikováno v: Urology [Urology] 2024 Aug; Vol. 190, pp. 13-14. Date of Electronic Publication: 2024 May 31.

Co-resistance Among Escherichia coli and Klebsiella pneumoniae Urine Isolates from Female Outpatients with Presumed UTI: A Retrospective US Cohort Study.

Autor: Kaye KS; Division of Allergy, Immunology and Infectious Diseases, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Gupta V; MMS Medical Affairs, Becton, Dickinson and Company, Franklin Lakes, NJ, USA., Mulgirigama A; Antibiotics, GSK, Brentford, London, UK., Joshi AV; Value Evidence and Outcomes, GSK, Collegeville, PA, USA., Scangarella-Oman NE; Diagnostics and Clinical Microbiology, GSK, Collegeville, PA, USA., Yu K; Medical and Scientific Affairs, Becton, Dickinson and Company, Franklin Lakes, NJ, USA., Watts J; Data Science and Analytics, Becton, Dickinson and Company, Franklin Lakes, NJ, USA., Mitrani-Gold FS; Epidemiology, GSK, Collegeville, PA, 19460, USA. fanny.s.mitrani-gold@gsk.com.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2024 Jul; Vol. 13 (7), pp. 1715-1722. Date of Electronic Publication: 2024 Jun 06.